In August 2026, AI confidence saw a notable increase, as evidenced by the BCC Research AI Sentiment Index rising to 77.78 from 75.10 in July. This growth is attributed to a shift from mere experimentation to the practical deployment of AI, with organizations reporting measurable efficiency gains and improved decision-making. Notably, life sciences and healthcare experienced significant advancements due to expanding AI applications, while the technology and consumer electronics sectors continued to lead in AI spending. The chemical and energy industries also saw substantial growth in disruption scores, highlighting AI's potential as a competitive edge despite varying infrastructure readiness. These findings underscore a broader industry movement towards more focused and value-driven AI investments.

In other trading, Jentech Precision Industrial (TWSE:3653) was a notable mover up 9.9% and finishing the session at NT$6,410.00. At the same time, Shanghai Iluvatar CoreX Semiconductor (SEHK:9903) softened, down 8.8% to end the day at HK$127.20.

Capitalize on Micron Technology's growth potential in AI-driven memory products now. Click to explore Micron's strategic positioning in this expanding market.

For a deeper dive into the AI Chips investment landscape, see our recent Market Insights article, which explores the driving force of AI spending on tech earnings and potential sustainability concerns—read it before it's too late to capitalize.

Best AI Chip Stocks

• Micron Technology (NasdaqGS:MU) finished trading at $1,096.16 up 5%.
• NVIDIA (NasdaqGS:NVDA) ended the day at $228.87 up 0.7%, close to the 52-week high. On Tuesday, the company announced a collaboration with Einride AB to advance autonomous freight operations using its DRIVE Hyperion platform.
• Broadcom (NasdaqGS:AVGO) closed at $364.54 up 0.5%.

Seize The Opportunity

• Access the full spectrum of 129 AI Chip Stocks including BE Semiconductor Industries, Intel and Hangzhou Changchuan TechnologyLtd by clicking on this link.
• Searching for a Fresh Perspective? AI is about to change healthcare. These 132 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Sources:

• Simply Wall St
• "AI Confidence Surges in August 2026 as Operational Proof Displaces Experimentation" from BCC Research LLC on GlobeNewswire (published 21 September 2026)

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.